脱颗粒
细胞毒性T细胞
细胞生物学
淋巴因子激活杀伤细胞
生物
K562细胞
白细胞介素21
白细胞介素12
免疫学
脐带血
川地34
体外
化学
干细胞
白血病
生物化学
受体
作者
Anna Domogala,J. Alejandro Madrigal,Aurore Saudemont
出处
期刊:Cytotherapy
[Elsevier]
日期:2016-06-01
卷期号:18 (6): 754-759
被引量:46
标识
DOI:10.1016/j.jcyt.2016.02.008
摘要
Background aims Natural killer (NK) cells offer the potential for a powerful cellular immunotherapy because they can target malignant cells without being direct effectors of graft-versus-host disease. We have previously shown that high numbers of functional NK cells can be differentiated in vitro from umbilical cord blood (CB) CD34+ cells. To develop a readily available, off-the-shelf cellular product, it is essential that NK cells differentiated in vitro can be frozen and thawed while maintaining the same phenotype and functions. Methods We evaluated the phenotype and function of fresh and frozen NK cells differentiated in vitro. We also assessed whether the concentration of NK cells at the time of freezing had an impact on cell viability. Results We found that cell concentration of NK cells at the time of freezing did not have an impact on their viability and on cell recovery post-thaw. Moreover, freezing of differentiated NK cells in vitro did not affect their phenotype, cytotoxicity and degranulation capacity toward K562 cells, cytokine production and proliferation. Conclusions We are therefore able to generate large numbers of functional NK cells from CB CD34+ cells that maintain the same phenotype and function post-cryopreservation, which will allow for multiple infusions of a highly cytotoxic NK cell product.
科研通智能强力驱动
Strongly Powered by AbleSci AI